Transactions
89bio, Inc.'s sale to Roche Holding AG
Date Announced:
09/18/2025
client:
89bio, Inc.
Status:
Pending
Value:
Up to $3.5 billion
Date Announced:
09/18/2025
client:
89bio, Inc.
Status:
Pending
Value:
Up to $3.5 billion
